サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1797198

ウシ血漿分画製剤の世界市場

Bovine Blood Plasma Derivatives

出版日
ページ情報
英文 289 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
ウシ血漿分画製剤の世界市場
出版日: 2025年08月25日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 289 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ウシ血漿分画製剤の世界市場は2030年までに24億米ドルに到達

2024年に19億米ドルと推定されるウシ血漿分画製剤の世界市場は、分析期間2024-2030年にCAGR 3.9%で成長し、2030年には24億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである免疫グロブリン誘導体は、CAGR 3.2％を記録し、分析期間終了時には6億7,170万米ドルに達すると予想されます。フィブリノゲン誘導体セグメントの成長率は、分析期間中CAGR 5.2%と推定されます。

米国市場は5億1,510万米ドルと推定、中国はCAGR 7.1％で成長すると予測

米国のウシ血漿分画製剤市場は、2024年には5億1,510万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを7.1%として、2030年までに4億7,920万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.7%と3.0%と予測されています。欧州では、ドイツがCAGR 2.3%で成長すると予測されています。

世界のウシ血漿分画製剤市場- 主要動向と促進要因のまとめ

なぜウシ血漿分画製剤はバイオメディカルおよび動物栄養産業にとって重要なのか？

ウシ血漿分画製剤は、特に生物医学研究、医薬品製造、動物栄養学など、様々な分野で不可欠な成分として浮上しています。牛血液の血漿画分から得られるこれらの誘導体には、アルブミン、免疫グロブリン、フィブリノゲン、成長因子などの機能性タンパク質が豊富に含まれています。バイオメディカル分野では、培地添加剤、ワクチンの安定化剤、薬剤製剤のキャリアーとして広く使用されています。ヒトや動物の細胞系に適合することから、組織工学、診断学、バイオ医薬品の開発に理想的です。動物栄養産業では、牛血漿タンパク質は高品質の飼料添加物として、特に子豚や子牛の飼料に使用され、成長初期の免疫サポートや腸内環境の改善に役立っています。牛血漿を飼料に使用することで、成長成績が向上するだけでなく、抗生物質の必要性を減らすことができ、抗生物質を使用しない畜産を目指す世界の動きと一致します。さらに、これらの誘導体は厳格な安全プロトコルのもとで加工されるため、病原菌のリスクが低く、生物活性も安定しています。持続可能な供給源からの機能性タンパク質への需要は着実に高まっており、ウシ血漿分画製剤は、食肉加工の製品別として利用されるものを利用する、費用対効果の高いソリューションを提供します。ウシ血漿分画製剤は、食肉加工の製品別であったものを利用することで、費用対効果の高いソリューションを提供します。世界の人口が増加し、生物医学製品と動物性タンパク質の両方の需要が高まる中、ウシ血漿分画製剤は、健康成果と栄養パフォーマンスを向上させるために、各分野で重要かつ拡大する役割を果たし続けています。

処理と精製の進歩は、血漿誘導体の品質と用途をどのように高めているのか？

処理、分画、精製における技術の進歩は、ウシ血漿分画製剤の品質、一貫性、応用範囲を大幅に向上させています。膜濾過、クロマトグラフィー技術、噴霧乾燥などの洗練された分離技術により、現在では個々の血漿タンパク質を最小限の変性で正確に分離することができます。このような改良により、より高い生物学的活性、より優れた溶解性、より標準化された製剤が保証され、これらは医薬品や診断用途に不可欠です。飼料用途では、低温噴霧乾燥技術によって免疫グロブリンやペプチドの生物活性が維持され、最終製品が動物の免疫反応を調節し、腸の健康を促進する上でより効果的になります。プロテオミクス分析とバイオアッセイは、血漿由来のタンパク質のプロファイリングと特性解析にますます使用されるようになっており、特定の機能性を持つ標的製剤の開発を可能にしています。さらに、ウイルスの不活化ステップやバッチのトレーサビリティを含む厳格な品質保証プロトコールにより、これらの誘導体の安全性プロファイルは、ヒトおよび動物用アプリケーションの両方において強化されています。バイオテクノロジー企業もまた、牛血漿成分の機能的特性を模倣または強化する組換え技術を探求しており、治療の可能性をさらに広げています。カプセル化やナノ製剤化における技術革新は、ドラッグデリバリー用途に新たな扉を開きつつあり、牛アルブミンやグロブリンが医薬品有効成分のキャリアとして使用されています。このような技術的進歩は、さまざまな市場において一貫性、安全性、有効性を確保することで、規制当局の受け入れも後押ししています。その結果、ウシ血漿分画製剤は基本的な機能性素材から、最先端の治療・栄養ソリューションに使用される高度に洗練されたバイオ機能性素材へと移行しつつあります。

世界のウシ血漿分画製剤の需要を形成している地域および業界固有の要因とは？

ウシ血漿分画製剤の世界需要は、地域ごとの規制、業界力学、セクター固有の優先事項の影響を強く受けています。北米と西欧では、活発な生物医学研究、高度な医薬品製造、高度に発達した畜産業が、高純度血漿タンパク質の一貫した需要を牽引しています。また、これらの地域では動物由来材料に関する厳しい規制の枠組みが維持されており、メーカーがトレーサブルな調達と有効な加工技術に投資することを奨励しています。アジア太平洋地域では、動物栄養学への投資の増加、高効率飼料原料への需要の増加、中国、インド、韓国などの国々におけるバイオ医薬品能力の急速な開拓により、市場が急速に拡大しています。ラテンアメリカ、特にブラジルとアルゼンチンは、牛の頭数が多く、輸出インフラが整備されつつあることから、牛の原血の主要供給国として台頭しつつあり、この地域を世界・サプライ・チェーンの重要なリンクとして位置づけています。中東とアフリカの一部では、食肉消費の増加と近代的な飼料産業の開発により、血漿ベースの動物用飼料サプリメントに新たな機会が生まれています。製薬会社は注射剤や経口剤の製剤用に高純度で病原体のない誘導体を要求し、飼料会社は家畜の腸管免疫と飼料効率を高める生物活性タンパク質ブレンドを優先します。機能性食品と栄養補助食品への関心の高まりも応用の境界を押し広げつつあり、研究者は血漿由来のペプチドをヒトの栄養と健康に利用することを模索しています。こうした多面的な地域的・部門的力学が、多様化しつつも相互の結びつきを強めている牛血漿由来製品の世界市場を形成しています。

ウシ血漿分画製剤市場の成長を促進する主な要因は何か？

ウシ血漿分画製剤市場の成長は、健康に焦点を当てたイノベーションの集結、持続可能なタンパク質源に対する需要の増加、動物およびヒトのヘルスケアソリューションに対する世界のニーズの高まりによってもたらされます。特に豚と子牛の栄養において、血漿タンパク質の飼料への利用が拡大しており、初期の免疫発達をサポートし、死亡率を低下させ、飼料転換効率を向上させることが大きな推進力となっています。抗生物質耐性に対する世界の動向が懸念される中、血漿のような機能性飼料原料の使用は抗生物質の自然な代替品と見なされ、持続可能で責任ある畜産を目指す業界の動向と一致しています。バイオメディカル分野では、細胞培養培地、タンパク質ベースの安定剤、治療用賦形剤に対する需要の高まりが、高純度血漿誘導体の必要性を加速させています。特にワクチン、モノクローナル抗体、再生療法などのバイオ医薬品開発が急増しているため、その適合性と性能が証明された血漿由来成分への依存度が高まっています。また、動物性製品別を血漿タンパク質のような高価値の素材に変えることで、廃棄物を減らし、食肉生産システム全体の資源効率を高めることができるため、持続可能性も極めて重要な役割を果たしています。さらに、加工技術の進歩や規制の枠組み強化により、市場全体の信頼と採用が高まっています。家畜の生産性向上、ヘルスケア研究、タンパク質工学への投資の増加は、市場の拡大にさらに貢献しています。農業、バイオテクノロジー、医薬品の融合が加速し続ける中、ウシ血漿分画製剤は、栄養ギャップを埋め、治療成果を改善し、世界経済全体に費用対効果の高い機能的ソリューションを提供する上で不可欠な存在であり続けると予想されます。

セグメント

誘導体（免疫グロブリン誘導体、フィブリノーゲン誘導体、ウシ血清アルブミン誘導体、ウシ胎児血清誘導体、新生子牛血清誘導体、トロンビン誘導体、その他誘導体）、エンドユーザー（産業エンドユーザー、製薬・バイオテクノロジー企業エンドユーザー、学術・研究機関エンドユーザー、食品エンドユーザー、その他エンドユーザー）

調査対象企業の例

  • Akron Biotech
  • Bio-Rad Laboratories, Inc.
  • Biowest SAS
  • Bovogen Biologicals Pty Ltd
  • CellSera Australasia Pty Ltd
  • Gemini Bio Products
  • GE Healthcare（now Cytiva）
  • Hemo Bioscience, Inc.
  • Kraeber & Co GmbH
  • Lake Immunogenics, Inc.
  • LAMPIRE Biological Laboratories
  • Merck KGaA（MilliporeSigma）
  • Moregate Biotech
  • MP Biomedicals
  • PAN-Biotech GmbH
  • Proliant Biologicals
  • Quad Five
  • Rocky Mountain Biologicals
  • Serana Europe GmbH
  • Thermo Fisher Scientific Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP38582

Global Bovine Blood Plasma Derivatives Market to Reach US$2.4 Billion by 2030

The global market for Bovine Blood Plasma Derivatives estimated at US$1.9 Billion in the year 2024, is expected to reach US$2.4 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Immunoglobulin Derivative, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$671.7 Million by the end of the analysis period. Growth in the Fibrinogen Derivative segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$515.1 Million While China is Forecast to Grow at 7.1% CAGR

The Bovine Blood Plasma Derivatives market in the U.S. is estimated at US$515.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$479.2 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Bovine Blood Plasma Derivatives Market - Key Trends & Drivers Summarized

Why Are Bovine Blood Plasma Derivatives Critical to the Biomedical and Animal Nutrition Industries?

Bovine blood plasma derivatives have emerged as vital components across several sectors, particularly in biomedical research, pharmaceutical manufacturing, and animal nutrition. These derivatives, obtained from the plasma fraction of bovine blood, are rich in functional proteins such as albumin, immunoglobulins, fibrinogen, and growth factors. In the biomedical field, they are widely used as culture media supplements, stabilizing agents for vaccines, and carriers for drug formulations. Their compatibility with human and animal cell systems makes them ideal for tissue engineering, diagnostics, and the development of biopharmaceuticals. In the animal nutrition industry, bovine plasma proteins serve as high-quality feed additives, especially in piglet and calf diets, promoting immune support and improving gut health during early growth stages. The use of bovine blood plasma in feed not only enhances growth performance but also reduces the need for antibiotics, aligning with the global movement toward antibiotic-free animal husbandry. Furthermore, these derivatives are processed under stringent safety protocols, ensuring low pathogen risk and consistent bioactivity. The demand for functional proteins from sustainable sources is steadily increasing, and bovine blood plasma derivatives provide a cost-effective solution that makes use of what would otherwise be a by-product of meat processing. This makes them environmentally beneficial while delivering high value to multiple end-use industries. As global populations grow and the demand for both biomedical products and animal protein rises, bovine blood plasma derivatives continue to play a crucial and expanding role in enhancing health outcomes and nutritional performance across sectors.

How Are Advances in Processing and Purification Elevating the Quality and Applications of Plasma Derivatives?

Technological advancements in processing, fractionation, and purification are greatly enhancing the quality, consistency, and scope of applications for bovine blood plasma derivatives. Sophisticated separation technologies, including membrane filtration, chromatographic techniques, and spray drying, now allow for precise isolation of individual plasma proteins with minimal denaturation. These improvements ensure higher biological activity, better solubility, and more standardized formulations, which are essential for pharmaceutical and diagnostic use. In feed applications, low-temperature spray drying techniques preserve the bioactivity of immunoglobulins and peptides, making the final product more effective in modulating the immune response and promoting gut health in animals. Proteomic analysis and bioassays are increasingly used to profile and characterize plasma-derived proteins, enabling the development of targeted formulations with specific functionalities. Additionally, stringent quality assurance protocols, including viral inactivation steps and batch traceability, have strengthened the safety profile of these derivatives for both human and veterinary applications. Biotech companies are also exploring recombinant technologies to mimic or enhance the functional properties of bovine plasma components, further expanding their therapeutic potential. Innovations in encapsulation and nano-formulation are opening new doors for drug delivery applications, where bovine albumin and globulins are used as carriers for active pharmaceutical ingredients. These technological strides are also supporting regulatory acceptance by ensuring consistency, safety, and efficacy across different markets. As a result, bovine blood plasma derivatives are transitioning from basic functional ingredients to highly refined bio-functional materials used in cutting-edge therapeutic and nutritional solutions.

What Regional and Industry-Specific Factors Are Shaping the Demand for Bovine Plasma Derivatives Worldwide?

The global demand for bovine blood plasma derivatives is highly influenced by regional regulations, industry dynamics, and sector-specific priorities. In North America and Western Europe, robust biomedical research, advanced pharmaceutical manufacturing, and highly developed livestock industries drive consistent demand for high-purity plasma proteins. These regions also maintain strict regulatory frameworks around animal-derived materials, encouraging manufacturers to invest in traceable sourcing and validated processing techniques. In Asia-Pacific, the market is expanding rapidly due to growing investments in animal nutrition, increased demand for high-efficiency feed ingredients, and the rapid development of biopharmaceutical capabilities in countries like China, India, and South Korea. Latin America, particularly Brazil and Argentina, is emerging as a major supplier of raw bovine blood due to its large cattle population and growing export infrastructure, positioning the region as a critical link in the global supply chain. In the Middle East and parts of Africa, rising meat consumption and the development of modern feed industries are also creating new opportunities for plasma-based animal feed supplements. Sector-specific trends further influence usage, with pharmaceutical firms demanding highly purified, pathogen-free derivatives for injectable and oral drug formulations, while feed companies prioritize bioactive protein blends that enhance gut immunity and feed efficiency in livestock. The growing interest in functional foods and nutraceuticals is also pushing the boundaries of application, with researchers exploring the use of plasma-derived peptides for human nutrition and wellness. These multifaceted regional and sectoral dynamics are contributing to a diversified yet increasingly interconnected global market for bovine plasma derivatives.

What Are the Primary Drivers Fueling the Growth of the Bovine Blood Plasma Derivatives Market?

The growth in the bovine blood plasma derivatives market is driven by a convergence of health-focused innovations, increasing demand for sustainable protein sources, and the rising global need for both animal and human healthcare solutions. A significant driver is the expanding use of plasma proteins in animal feed, especially in swine and calf nutrition, where they support early immune development, reduce mortality rates, and improve feed conversion efficiency. With global concerns over antibiotic resistance, the use of functional feed ingredients like plasma is seen as a natural alternative to antibiotics, aligning with industry trends toward sustainable and responsible animal agriculture. In the biomedical field, growing demand for cell culture media, protein-based stabilizers, and therapeutic excipients is accelerating the need for high-purity plasma derivatives. The surge in biopharmaceutical development, particularly for vaccines, monoclonal antibodies, and regenerative therapies, has intensified reliance on plasma-based components due to their proven compatibility and performance. Sustainability also plays a pivotal role, as the valorization of animal by-products into high-value materials like plasma proteins reduces waste and enhances overall resource efficiency within the meat production system. Additionally, advancements in processing and a stronger regulatory framework have increased trust and adoption across markets. Increased investments in livestock productivity, healthcare research, and protein engineering further contribute to market expansion. As the convergence of agriculture, biotechnology, and pharmaceuticals continues to accelerate, bovine blood plasma derivatives are expected to remain essential in bridging nutritional gaps, improving therapeutic outcomes, and delivering cost-effective, functional solutions across the global economy.

SCOPE OF STUDY:

The report analyzes the Bovine Blood Plasma Derivatives market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Derivative (Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative, Other Derivatives); End-User (Industrial End-User, Pharma & Biotech Companies End-User, Academic & Research Institutes End-User, Food End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Akron Biotech
  • Bio-Rad Laboratories, Inc.
  • Biowest SAS
  • Bovogen Biologicals Pty Ltd
  • CellSera Australasia Pty Ltd
  • Gemini Bio Products
  • GE Healthcare (now Cytiva)
  • Hemo Bioscience, Inc.
  • Kraeber & Co GmbH
  • Lake Immunogenics, Inc.
  • LAMPIRE Biological Laboratories
  • Merck KGaA (MilliporeSigma)
  • Moregate Biotech
  • MP Biomedicals
  • PAN-Biotech GmbH
  • Proliant Biologicals
  • Quad Five
  • Rocky Mountain Biologicals
  • Serana Europe GmbH
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Bovine Blood Plasma Derivatives - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for High-Quality Protein Supplements Throws the Spotlight on Bovine Blood Plasma Derivatives
    • Growth in Animal Nutrition and Feed Efficiency Solutions Spurs Use of Plasma-Derived Functional Proteins
    • Here's the Story: How Immunoglobulin-Rich Derivatives Are Gaining Traction in Livestock Health Management
    • Expansion of the Pet Food Industry Strengthens Business Case for Bioactive Plasma Ingredients
    • Increased Focus on Gut Health and Disease Prevention in Swine and Poultry Drives Adoption of Spray-Dried Plasma
    • Biopharmaceutical Research and Cell Culture Applications Expand Addressable Market for Plasma Proteins
    • Here's How Regulatory Approvals and Safety Protocols Are Shaping Market Access Across Global Regions
    • Growing Demand for Sustainable and Circular Agriculture Practices Propels Interest in Valorized Animal Byproducts
    • Rising Feed Ingredient Costs Throw the Spotlight on Plasma as a High-Efficiency Alternative Protein Source
    • Technological Advancements in Plasma Fractionation and Purification Improve Product Quality and Functional Yield
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bovine Blood Plasma Derivatives Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bovine Blood Plasma Derivatives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Bovine Blood Plasma Derivatives by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Immunoglobulin Derivative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Immunoglobulin Derivative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Immunoglobulin Derivative by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Fibrinogen Derivative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Fibrinogen Derivative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Fibrinogen Derivative by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Bovin Serum Albumin Derivative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Bovin Serum Albumin Derivative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Bovin Serum Albumin Derivative by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Fetal Bovin Serum Derivative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Fetal Bovin Serum Derivative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Fetal Bovin Serum Derivative by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Newborn Calf Serum Derivative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Newborn Calf Serum Derivative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Newborn Calf Serum Derivative by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Thrombin Derivative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Thrombin Derivative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Thrombin Derivative by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Derivatives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Derivatives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Derivatives by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Academic & Research Institutes End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Academic & Research Institutes End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Food End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Food End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Food End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Industrial End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Industrial End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Industrial End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Pharma & Biotech Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Pharma & Biotech Companies End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bovine Blood Plasma Derivatives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • JAPAN
    • Bovine Blood Plasma Derivatives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • CHINA
    • Bovine Blood Plasma Derivatives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: China 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: China 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • EUROPE
    • Bovine Blood Plasma Derivatives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Bovine Blood Plasma Derivatives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Bovine Blood Plasma Derivatives by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • FRANCE
    • Bovine Blood Plasma Derivatives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: France 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: France 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • GERMANY
    • Bovine Blood Plasma Derivatives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Italy 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Bovine Blood Plasma Derivatives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 92: UK Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 95: UK Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: UK Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: UK 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Spain 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 101: Spain Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Spain Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Spain 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Russia 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 107: Russia Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Russia Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Russia 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Rest of Europe 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Bovine Blood Plasma Derivatives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Bovine Blood Plasma Derivatives by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Bovine Blood Plasma Derivatives by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Asia-Pacific 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Bovine Blood Plasma Derivatives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Australia 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 128: Australia Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Australia Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Australia 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • INDIA
    • Bovine Blood Plasma Derivatives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 131: India Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: India 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 134: India Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: India Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: India 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: South Korea 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 140: South Korea Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: South Korea Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: South Korea 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Asia-Pacific Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Rest of Asia-Pacific 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Bovine Blood Plasma Derivatives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Bovine Blood Plasma Derivatives by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Bovine Blood Plasma Derivatives by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Latin America 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Latin America 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Argentina 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 161: Argentina Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Argentina Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Argentina 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Brazil 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 167: Brazil Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Brazil Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Brazil 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Mexico 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 173: Mexico Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Mexico Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Mexico 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Rest of Latin America 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Latin America Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Rest of Latin America 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Bovine Blood Plasma Derivatives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Bovine Blood Plasma Derivatives by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Bovine Blood Plasma Derivatives by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Middle East 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Middle East 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Iran 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 194: Iran Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Iran Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Iran 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Israel 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 200: Israel Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Israel Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Israel 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Saudi Arabia 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Saudi Arabia Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Saudi Arabia 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: UAE 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 212: UAE Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: UAE Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: UAE 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Rest of Middle East 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Rest of Middle East Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Rest of Middle East 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030
  • AFRICA
    • Bovine Blood Plasma Derivatives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Bovine Blood Plasma Derivatives by Derivative - Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Africa 16-Year Perspective for Bovine Blood Plasma Derivatives by Derivative - Percentage Breakdown of Value Sales for Immunoglobulin Derivative, Fibrinogen Derivative, Bovin Serum Albumin Derivative, Fetal Bovin Serum Derivative, Newborn Calf Serum Derivative, Thrombin Derivative and Other Derivatives for the Years 2014, 2025 & 2030
    • TABLE 224: Africa Recent Past, Current & Future Analysis for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Africa Historic Review for Bovine Blood Plasma Derivatives by End-user - Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Africa 16-Year Perspective for Bovine Blood Plasma Derivatives by End-user - Percentage Breakdown of Value Sales for Academic & Research Institutes End-User, Food End-User, Other End-Users, Industrial End-User and Pharma & Biotech Companies End-User for the Years 2014, 2025 & 2030

IV. COMPETITION